in the absence of a submission from the holder of the marketing authorisation:
prasterone (Intrarosa®) is not recommended for use within NHSScotland.
Indication under review: For the treatment of vulvar and vaginal atrophy in postmenopausal women having moderate to severe symptoms.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.
Download detailed advice350KB (PDF)
- Medicine name:
- prasterone (Intrarosa)
- SMC ID:
Treatment of vulvar and vaginal atrophy in postmenopausal women having moderate to severe symptoms.
- Pharmaceutical company
- Theramex UK LTD
- BNF chapter
- Submission type
- Non submission
- Not recommended
- Date advice published:
- 09 December 2019